Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 5
Review
Targeting the kidney and glucose excretion with dapagliflozin: preclinical and clinical evidence for SGLT2 inhibition as a new option for treatment of type 2 diabetes mellitus
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
27,377 | Dovepress* | 14,527+ | 3,852 | 18,379 | |
PubMed Central* | 12,850 | 2,801 | 15,651 | ||
Totals | 27,377 | 6,653 | 34,030 | ||
*Since 23 July 2012 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 0 | 4 |
View citations on PubMed Central and Google Scholar